Development and Validation of Spectrophotometric Methods for the Determination of Rasagiline in Pharmaceutical Preparations

Figure 1

(A): (a) Absorption spectrum of 35 μg mL⁻¹ of the product occurred in method A against reagent blank and (a′) absorption spectrum of the reagent blank of method A. (B): (b) Absorption spectrum of 30 μg mL⁻¹ of the product occurred in method B against reagent blank and (b′) absorption spectrum of the reagent blank of method B. (C): (c) Absorption spectrum of 55 μg mL⁻¹ of the product occurred in method C against reagent blank and (c′) absorption spectrum of the reagent blank of method C.